Browse
related articles
Smoking cessation drugs to have warnings
- Middle East: Thursday, July 02 - 2009 at 11:20
The US Food and Drugs Administration (FDA) has ordered Pfizer Inc. and GlaxoSmithKline PLC to add strong 'black box' warnings on Pfizer's Chantix and Glaxo's Zyban, smoking cessation drugs to highlight a risk of serious mental health problems including changes in behavior, depressed mood, hostility, and suicidal thoughts. Pfizer has said it had added the warning to the prescribing instructions for its drug.
Related Content
Article Options
StaffThursday, July 02 - 2009 at 11:20 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer »
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
